OLYMPUS CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,181 JPY | -0.27% |
|
+3.94% | +6.79% |
| Apr. 08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| Mar. 28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Sales 2024 * | 929B 5.97B | Sales 2025 * | 988B 6.35B | Capitalization | 2,549B 16.38B |
|---|---|---|---|---|---|
| Net income 2024 * | 259B 1.66B | Net income 2025 * | 110B 710M | EV / Sales 2024 * | 2.66 x |
| Net cash position 2024 * | 78.83B 506M | Net cash position 2025 * | 127B 813M | EV / Sales 2025 * | 2.45 x |
| P/E ratio 2024 * |
10.2
x | P/E ratio 2025 * |
23.6
x | Employees | 32,844 |
| Yield 2024 * |
0.82% | Yield 2025 * |
0.91% | Free-Float | 88.47% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | -0.37% | ||
| 1 week | +3.94% | ||
| Current month | -1.51% | ||
| 1 month | +1.28% | ||
| 3 months | +0.44% | ||
| 6 months | +12.81% | ||
| Current year | +6.79% |
1 week
2 125.50
2 230.00
1 month
2 050.002 293.00
Current year
1 935.502 304.00
1 year
1 782.002 482.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
752.503 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 19-05-31 |
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 61 | 22-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 31 M€ | +10.08% | ||
| 2.11% | 11 M€ | +10.71% | - | |
| 1.55% | 251 M€ | +13.17% | ||
| 1.23% | 31,732 M€ | +13.41% | - | |
| 1.22% | 1,198 M€ | +12.53% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2,181 | -0.27% | 521 900 |
| 24-04-25 | 2,187 | -1.82% | 2,890,300 |
| 24-04-24 | 2,228 | +2.46% | 2,774,700 |
| 24-04-23 | 2,174 | +0.14% | 2,493,400 |
| 24-04-22 | 2,171 | +3.55% | 4,617,300 |
Delayed Quote Japan Exchange, April 25, 2024 at 08:31 pm EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-05-09
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,187
JPY
Average target price
2,426
JPY
Spread / Average Target
+10.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.79% | 16.74B | |
| +7.71% | 220B | |
| +6.25% | 185B | |
| +10.60% | 133B | |
| +26.73% | 107B | |
| -0.57% | 62.91B | |
| +15.42% | 53.34B | |
| -1.89% | 47.71B | |
| -1.91% | 40.29B | |
| +11.16% | 39.57B |
- Stock Market
- Equities
- 7733 Stock
